Search results
Results From The WOW.Com Content Network
Minoxidil was the most effective of the three. So, if you’re looking for proven hair loss treatments, minoxidil (or finasteride, for that matter) is definitely a better bet than ketoconazole ...
This is a partial list of herbs and herbal treatments with known or suspected adverse effects, either alone or in interaction with other herbs or drugs. Non-inclusion of an herb in this list does not imply that it is free of adverse effects.
Rumination syndrome, or merycism, is a chronic motility disorder characterized by effortless regurgitation of most meals following consumption, due to the involuntary contraction of the muscles around the abdomen. [ 1] There is no retching, nausea, heartburn, odour, or abdominal pain associated with the regurgitation as there is with typical ...
Depending on the formulation, the most common topical minoxidil side effects are: Skin irritation at the application site. Scalp itchiness. Slight burning sensation. Skin rash. These adverse ...
Side effects in adults. Common adverse drug reactions (≥ 1% of people) associated with use of the penicillins include diarrhea, hypersensitivity, nausea, rash, neurotoxicity, urticaria (hives), and superinfection (including candidiasis ). Infrequent adverse effects (0.1–1% of people) include fever, vomiting, erythema, dermatitis, angioedema ...
For instance, vitamin B deficiency hair loss is also possible. Vitamin D and Hair Loss: Key Info. Vitamin D is an essential, fat-soluble vitamin that plays a role in numerous biological processes ...
Nasal budesonide inhalers have been associated with a number of side effects. [ 34 ] [ 35 ] These include nose irritation or burning, bleeding or sores in the nose, lightheadedness, upset stomach, cough, hoarseness, dry mouth, rash, sore throat, bad taste in mouth , change in mucus , and blurred vision. [ 36 ]
Additionally, side effects common in cosmetic use are also common in therapeutic use, including trouble swallowing, muscle weakness, allergic reactions, and flu-like syndromes. [71] In response to the occurrence of these side effects, in 2008, the FDA notified the public of the potential dangers of the botulinum toxin as a therapeutic.